US giant Edwards Lifesciences’ acquisition of Israel’s Innovalve Bio Medical will enable its innovative catheterization system to replace the diseased mitral valves of millions of patients, avoiding open-heart surgery. The system was originally developed at Israel’s Sheba Medical Center.

https://www.ynetnews.com/health_science/article/b1fsw8sua

https://www.innovalvemed.com/